Pharmaceuticals; therapeutic agents; pharmaceuticals and therapeutics for the treatment of liver diseases, cirrhosis, hepatitis, metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver diseases, liver fibrosis, primary biliary cholangitis, fibrotic diseases and metabolic diseases; pharmaceuticals and therapeutics for the treatment of obesity, sarcopenia, metabolic disorders and muscular disorders; pharmaceuticals and therapeutics for the treatment of conditions affecting the ...